Clinical potential of the mTOR effectors S6K1, S6K2 and 4EBP1 in breast cancer

Clinical potential of the mTOR effectors S6K1, S6K2 and 4EBP1 in breast cancer

The prognosis of patients diagnosed with breast cancer has been considerably improved in the latest 25 years, as a result of continuous development of diagnostics and treatment regimens. Though, tumour diseases, for woman mainly lung cancer and breast cancer, still constitute of the most common caus...

Full description

Bibliographic Details
Main Author:	Karlsson, Elin
Format:	Doctoral Thesis
Language:	English
Published:	Linköpings universitet, Avdelningen för kliniska vetenskaper 2014
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-104180 http://nbn-resolving.de/urn:isbn:978-91-7519-432-5 (print)

Similar Items

Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer
by: Savitha Sridharan, et al.
Published: (2020-02-01)

Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and mTOR/ P70S6K/4EBP1 Signaling
by: Juan Jin, et al.
Published: (2018-07-01)

Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.
by: Elin Karlsson, et al.
Published: (2015-01-01)

Role of PI3K/mTOR/S6K1 signaling pathway in Diabetic Nephropathy
by: Chu-Yun Cheng, et al.
Published: (2011)

The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer
by: Tinghui Duan, et al.
Published: (2021-09-01)

Sulforaphane regulates AKT/mTOR/S6K pathway in human breast cancer cells
by: Chiao-Ying Lien, et al.
Published: (2014)

Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1.
by: Sharmila Mallya, et al.
Published: (2014-01-01)

Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer
by: Hautaniemi Sampsa, et al.
Published: (2008-07-01)

mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division
by: Martina Bonucci, et al.
Published: (2020-06-01)

PI3K/Akt/mTOR inhibitors in breast cancer
by: Joycelyn JX Lee, et al.
Published: (2015-12-01)

Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice[S]
by: Zhenjiang Liu, et al.
Published: (2016-08-01)

Huaier Extract Induces Autophagic Cell Death by Inhibiting the mTOR/S6K Pathway in Breast Cancer Cells.
by: Xiaolong Wang, et al.
Published: (2015-01-01)

Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling
by: Minjing Li, et al.
Published: (2017-12-01)

The mTOR/p70S6K1 signaling pathway in renal fibrosis of children with immunoglobulin A nephropathy
by: Yuanyuan Xu, et al.
Published: (2017-07-01)

Regulation of MDM2 stability and function by signalling from mTOR/S6K pathway
by: Wang, M.-L.
Published: (2008)

Expression profiles of mTOR, S6K1, Caveolin-1, Connexin-43, ER and AR in oral squamous cell carcinoma
by: Chieh-Ming Haung, et al.
Published: (2014)

Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways
by: Hosford SR, et al.
Published: (2014-08-01)

Association between PI3K/Akt/mTOR/p70S6K signaling pathway and hepatic fibrosis
by: WU Changhui, et al.
Published: (2015-11-01)

Interleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signaling.
by: Simone Codeluppi, et al.
Published: (2014-01-01)

Epigenetic downregulation of STAT6 increases HIF-1α expression via mTOR/S6K/S6, leading to enhanced hypoxic viability of glioma cells
by: Soo Jung Park, et al.
Published: (2019-09-01)

Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
by: Guobing Li, et al.
Published: (2015-01-01)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
by: Huayi Li, et al.
Published: (2021-07-01)

4′,6-Dihydroxy-4-methoxyisoaurone Inhibits the HIF-1α Pathway Through Inhibition of Akt/mTOR/p70S6K/4E-BP1 Phosphorylation
by: Chunliu Mi, et al.
Published: (2014-01-01)

The critical role of IL-15-PI3K-mTOR pathway in Natural Killer cell effector functions
by: Neethi eNandagopal, et al.
Published: (2014-04-01)

PI3K/AKT/mTOR pathway in Angiogenesis
by: Jayashree eKarar, et al.
Published: (2011-12-01)

Targeting PI3K/mTOR signaling in cancer
Published: (2014)

LGR6 promotes the progression of gastric cancer through PI3K/AKT/mTOR pathway
by: Ke J, et al.
Published: (2018-05-01)

Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer
by: Wei Wen, et al.
Published: (2019-08-01)

PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy
by: Shengnuo Fan, et al.
Published: (2015-01-01)

PI3K-mTOR-S6K Signaling Mediates Neuronal Viability via Collapsin Response Mediator Protein-2 Expression
by: Eun J. Na, et al.
Published: (2017-09-01)

The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
by: Elisavet Paplomata, et al.
Published: (2014-07-01)

Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance
by: Zhang S, et al.
Published: (2020-07-01)

Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signaling
by: Li-Jun Zhang, et al.
Published: (2017-07-01)

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
by: Salihanur Darici, et al.
Published: (2020-09-01)

The Critical Role of PI3K-AKT-mTOR Pathway for IL-15 Induced NK Cell Effector Responses
by: Nandagopal, Neethi
Published: (2014)

Role of Yanghe Huayan Decoction in ER-PI3K/Akt/mTOR pathway of endocrine-resistant breast cancer cells with low mTOR expression
by: Xue Sun, et al.
Published: (2020-07-01)

AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines
by: Leal P, et al.
Published: (2013-10-01)

MECP2 Mutation Interrupts Nucleolin–mTOR–P70S6K Signaling in Rett Syndrome Patients
by: Carl O. Olson, et al.
Published: (2018-12-01)

Chitosan 3D Sphere Mediated Promotion of Chondrogenesis in hMSC Depends on mTOR-S6K Pathway
by: Tsai-Jung Lu, et al.
Published: (2016)

USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR/4EBP1 Activation
by: Li Y, et al.
Published: (2021-05-01)

Cannot write session to /tmp/vufind_sessions/sess_lc894hdb3qi6dpa7kv38eetttt